Andrew Bellinger - Jun 17, 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: Chief Scientific Officer
Signature: /s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
Stock symbol: VERV
Transactions as of: Jun 17, 2021
Transactions value $: $95,000
Form type: 4
Date filed: 6/21/2021, 06:21 PM
Previous filing: Jun 16, 2021
Next filing: Dec 17, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERV	Common Stock	Purchase	$95K	+5K		$19.00	5K	Jun 21, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERV	Stock Option (right to buy)	Award	$0	+21.6K		$0.00	21.6K	Jun 17, 2021	Common Stock	21.6K	$19.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 17, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 17, 2025.